AN UPDATED REVIEW ON ANALYTICAL METHODS FOR THE AZELNIDIPINE AND TELMISARTAN IN PHARMACEUTICAL DOSAGE FORM
AbstractHypertension, also known as high blood pressure, occurs when the force of blood against the artery walls is excessively high the force of blood against the artery wall is too high. Hypertension is a very common disorder, particularly in past middle age. For improvement activity of hypertension, Azelnidipine and Telmisartan are newer combination in the market which is effective in hypertension. This combination was developed to improve medication for stage II hypertension. Azelnidipine is a Calcium channel blocker, and Telmisartan is an Angiotensin II receptor blocker. This review provides information about different analytical methods for estimating Azelnidipine and Telmisartan individually or in combination with other drugs, such as UV spectrophotometry, HPTLC, HPLC, and LC-MS. All reported methods were found to be simple, accurate, economical, precise, and reproducible. This review focuses on the recent analytical method development of Azelnidipine and Telmisartan in their combined dosage form. It also includes a stability-indicating analytical method for determining Azelnidipine and Telmisartan.
Article Information
11
4331-4343
636 KB
551
English
IJPSR
Priya Bavishi, Puja Bhavsar *, Lima Patel and Zanza Patel
Department of Pharmaceutical Quality Assurance, Parul Institute of Pharmacy, Parul University, P.O Limda, Vadodara, Gujarat, India.
puja.bhavsar16123@paruluniversity.ac.in
23 December 2022
20 March 2023
30 May 2023
10.13040/IJPSR.0975-8232.14(9).4331-43
01 September 2023
Download